Top story Healthcare’s Next Competitive Edge Won’t Be a New Drug or Fancy AI – It’ll Be Leaders Who Know How to Use AI
A Bold New Chapter: Rare Ventures Launches with a $25 Million Bet on a Smarter Approach to Rare Disease Therapies